{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[15,2,15,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996209298303316"]
[null,null,"Autore",null,"Paudel Kalpana S."]
[null,null,"Titolo",null,"Therapeutic delivery"]
[null,null,"Pubbl/distr/stampa",null,"London, : Future Science"]
[{"$nulls":4},"London : , : Future Science, , 2010"]
[null,null,"ISSN",null,"2041-6008"]
[null,null,"Descrizione fisica",null,"1 online resource : illustrations (some colour)"]
[null,null,"Disciplina",null,"615.6"]
[null,null,"Soggetti",null,"Therapeutics"]
[{"$nulls":4},"Drug delivery systems"]
[{"$nulls":4},"Technology, Pharmaceutical"]
[{"$nulls":4},"Drug Administration Routes"]
[{"$nulls":4},"Drug Delivery Systems"]
[{"$nulls":4},"Periodical"]
[{"$nulls":4},"Periodicals."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Periodico"]
[null,null,null,"Note generali","Refereed/Peer-reviewed"]
[null,null,null,"Sommario/riassunto","Transdermal drug delivery is an exciting and challenging area. There are numerous transdermal delivery systems currently available on the market. However, the transdermal market still remains limited to a narrow range of drugs. Further advances in transdermal delivery depend on the ability to overcome the challenges faced regarding the permeation and skin irritation of the drug molecules. Emergence of novel techniques for skin permeation enhancement and development of methods to lessen skin irritation would widen the transdermal market for hydrophilic compounds, macromolecules and conventional drugs for new therapeutic indications. As evident from the ongoing clinical trials of a wide variety of drugs for various clinical conditions, there is a great future for transdermal delivery of drugs."]